REVIEW
Published on 08 Dec 2022
Involvement of the STING signaling in COVID-19
doi 10.3389/fimmu.2022.1006395
- 3,241 views
- 7 citations
- Frontiers in Immunology
- Viral Immunology
- Research Topics
- A year in review: Coronavirus infection in Humans and Viral Immunology
A year in review: Coronavirus infection in Humans and Viral Immunology
31k
Total downloads
150k
Total views and downloads
Articles
REVIEW
Published on 23 Nov 2022
Cellular immune states in SARS-CoV-2-induced disease
doi 10.3389/fimmu.2022.1016304
- 2,671 views
- 13 citations
ORIGINAL RESEARCH
Published on 14 Nov 2022
Dynamics of humoral immune response in SARS-CoV-2 infected individuals with different clinical stages
doi 10.3389/fimmu.2022.1007068
- 1,542 views
- 1 citation
CLINICAL TRIAL
Published on 09 Nov 2022
A pilot study for treatment of severe COVID-19 pneumonia by aerosolized formulation of convalescent human immune plasma exosomes (ChipEXO™)
doi 10.3389/fimmu.2022.963309
- 2,934 views
- 8 citations
REVIEW
Published on 27 Oct 2022
CD8+ T-cell immune escape by SARS-CoV-2 variants of concern
doi 10.3389/fimmu.2022.962079
- 4,006 views
- 18 citations
ORIGINAL RESEARCH
Published on 20 Oct 2022
Saliva antibody-fingerprint of reactivated latent viruses after mild/asymptomatic COVID-19 is unique in patients with myalgic-encephalomyelitis/chronic fatigue syndrome
doi 10.3389/fimmu.2022.949787
- 48,396 views
- 39 citations
ORIGINAL RESEARCH
Published on 17 Oct 2022
HLA-C dysregulation as a possible mechanism of immune evasion in SARS-CoV-2 and other RNA-virus infections
doi 10.3389/fimmu.2022.1011829
- 1,933 views
- 4 citations
ORIGINAL RESEARCH
Published on 28 Sep 2022
Correlation of antigen-specific immune response with disease severity among COVID-19 patients in Bangladesh
doi 10.3389/fimmu.2022.929849
- 2,861 views
- 8 citations
REVIEW
Published on 27 Sep 2022
N-3 polyunsaturated fatty acids may affect the course of COVID-19
doi 10.3389/fimmu.2022.957518
- 2,450 views
- 7 citations
ORIGINAL RESEARCH
Published on 23 Sep 2022
Reaction of SARS-CoV-2 antibodies with other pathogens, vaccines, and food antigens
doi 10.3389/fimmu.2022.1003094
- 13,166 views
- 16 citations
ORIGINAL RESEARCH
Published on 14 Sep 2022
Preclinical characterization of amubarvimab and romlusevimab, a pair of non-competing neutralizing monoclonal antibody cocktail, against SARS-CoV-2
doi 10.3389/fimmu.2022.980435
- 5,495 views
- 15 citations
CASE REPORT
Published on 12 Sep 2022
Case report: Understanding the impact of persistent tissue-localization of SARS-CoV-2 on immune response activity via spatial transcriptomic analysis of two cancer patients with COVID-19 co-morbidity
doi 10.3389/fimmu.2022.978760
- 4,000 views
- 3 citations
